16 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1407-1409
Number of pages3
JournalJournal of Clinical Investigation
Volume110
Issue number10
DOIs
StatePublished - Nov 1 2002

Fingerprint

NK Cell Lectin-Like Receptor Subfamily D
Immunologic Receptors
Immunological Models
CD Antigens
C-Type Lectins
Immune Tolerance
Cytotoxic T-Lymphocytes
Licensure
HLA Antigens
Natural Killer Cells
Interferon-gamma
Ligands
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{91ad9116254e4ee2b60305d2704d767d,
title = "IFN-γ suspends the killing license of anti-tumor CTLs",
author = "Aron Lukacher",
year = "2002",
month = "11",
day = "1",
doi = "10.1172/JCI200217209",
language = "English (US)",
volume = "110",
pages = "1407--1409",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

IFN-γ suspends the killing license of anti-tumor CTLs. / Lukacher, Aron.

In: Journal of Clinical Investigation, Vol. 110, No. 10, 01.11.2002, p. 1407-1409.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - IFN-γ suspends the killing license of anti-tumor CTLs

AU - Lukacher, Aron

PY - 2002/11/1

Y1 - 2002/11/1

UR - http://www.scopus.com/inward/record.url?scp=0036856108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036856108&partnerID=8YFLogxK

U2 - 10.1172/JCI200217209

DO - 10.1172/JCI200217209

M3 - Comment/debate

C2 - 12438437

AN - SCOPUS:0036856108

VL - 110

SP - 1407

EP - 1409

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -